KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Operating Leases: 2019-2024

Historic Operating Leases for Exact Sciences (EXAS) over the last 6 years, with Dec 2024 value amounting to $184.5 million.

  • Exact Sciences' Operating Leases rose 3.05% to $195.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.7 million, marking a year-over-year increase of 3.05%. This contributed to the annual value of $184.5 million for FY2024, which is 3.10% down from last year.
  • According to the latest figures from FY2024, Exact Sciences' Operating Leases is $184.5 million, which was down 3.10% from $190.4 million recorded in FY2023.
  • Exact Sciences' Operating Leases' 5-year high stood at $210.8 million during FY2022, with a 5-year trough of $132.6 million in FY2020.
  • In the last 3 years, Exact Sciences' Operating Leases had a median value of $190.4 million in 2023 and averaged $195.2 million.
  • Per our database at Business Quant, Exact Sciences' Operating Leases skyrocketed by 52.26% in 2021 and then declined by 9.68% in 2023.
  • Yearly analysis of 5 years shows Exact Sciences' Operating Leases stood at $132.6 million in 2020, then skyrocketed by 52.26% to $201.9 million in 2021, then rose by 4.41% to $210.8 million in 2022, then dropped by 9.68% to $190.4 million in 2023, then fell by 3.10% to $184.5 million in 2024.